New Stock Debut | Xinhehua (02206) Debuts, Opening 27.61% Higher in Early Trading; Company Is a Leading Chinese Supplier of Traditional Chinese Medicine Decoction Pieces

date
09:21 11/11/2026
avatar
GMT Eight
Xinhehua (02206) debuted on the market. According to the announcement, the offer price was HK$40.2 per share, with a total of 6.5173 million shares issued, and a board lot of 50 shares. Net proceeds were approximately HK$229 million. As of press time, the stock rose 27.61% to HK$51.3, with a turnover of HK$96.574 million.
Xinhehua (02206) debuted on the stock exchange. According to the announcement, the offer price was HK$40.2 per share, with a total of 6.5173 million shares issued, 50 shares per lot, and net proceeds of approximately HK$229 million. As of press time, the stock rose 27.61% to HK$51.3, with a turnover of HK$96.574 million. According to the prospectus, Xinhehua is a leading supplier of traditional Chinese medicine (TCM) decoction pieces products in China. According to Frost & Sullivan, based on 2025 revenue from TCM decoction pieces products, Xinhehua ranked No. 2 in China, holding a 0.4% market share in a highly competitive market landscape, while the top five market participants collectively held a 2.7% market share. The group serves a broad range of institutional and retail customersincluding hospitals and medical institutions, medical trading companies, pharmacies, pharmaceutical companies, and more recently individual consumersproviding traditional herbal preparations, health products, and health management services. The group's business covers most provinces in mainland China, as well as Hong Kong, Taiwan, and selected overseas markets such as Vietnam and Malaysia.